Toxicity Of Nivolumab & Ipilimumab: Were Still Learning How To Leverage These Treatments In The Pre-Operative Setting

Tina Cascone MD Of The University of Texas MD Anderson Cancer Center Discusses Toxicity Of Nivolumab & Ipilimumab: Were Still Learning How To Leverage These Treatments In The Pre-Operative Setting.<br /><br />... Author: Annual-Meeting Added: 06/06/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts